Cullinan Therapeutics Director David Meek Receives 25,319 Stock Options at $13.55 Exercise Price

This Form 4 filing discloses that David D. Meek, a director of Cullinan Therapeutics, Inc. (CGEM), was granted 25,319 stock options on June 16, 2026. The options have an exercise price of $13.55 per share and represent the right to purchase common stock. According to footnote F1, the options will vest in full on the earlier of June 16, 2027 or the date of the company's next annual meeting, subject to Meek's continued service as a director on the vesting date. The transaction was reported on June 18, 2026, and Meek now holds 25,319 options following this grant. The filing indicates this is a director-level transaction rather than an officer transaction.